These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32240715)

  • 21. Antibody- and genome-based identification of recent HCV infection.
    Araujo AC
    Antivir Ther; 2012; 17(7 Pt B):1459-64. PubMed ID: 23322615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody.
    Ward KN; Dhaliwal W; Ashworth KL; Clutterbuck EJ; Teo CG
    J Med Virol; 1994 Aug; 43(4):367-72. PubMed ID: 7525865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
    Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City.
    Tieu HV; Laeyendecker O; Nandi V; Rose R; Fernandez R; Lynch B; Hoover DR; Frye V; Koblin BA
    PLoS One; 2018; 13(7):e0200269. PubMed ID: 30020960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.
    Rosenberg ES; Hall EW; Sullivan PS; Sanchez TH; Workowski KA; Ward JW; Holtzman D
    Clin Infect Dis; 2017 Jun; 64(11):1573-1581. PubMed ID: 28449115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria.
    Nnakenyi ID; Uchechukwu C; Nto-Ezimah U
    Afr Health Sci; 2020 Jun; 20(2):579-586. PubMed ID: 33163019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.
    Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ
    Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
    Konikoff J; Brookmeyer R; Longosz AF; Cousins MM; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Justman JE; Hodder SL; Quinn TC; Eshleman SH; Laeyendecker O
    PLoS One; 2013; 8(12):e82772. PubMed ID: 24386116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of low-avidity IgG antibodies in the diagnosis of primary acute infection by hepatitis C virus].
    León P; López JA; de Ory F; Elola C; Echevarría JM
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):14-8. PubMed ID: 9147501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence estimates of HIV, syphilis, hepatitis B and C among female sex workers (FSW) in Brazil, 2016.
    Ferreira-Júnior ODC; Guimarães MDC; Damacena GN; de Almeida WDS; de Souza-Júnior PRB; Szwarcwald CL;
    Medicine (Baltimore); 2018 May; 97(1S Suppl 1):S3-S8. PubMed ID: 29912817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index.
    Coppola N; Pisapia R; Tonziello G; Masiello A; Martini S; Pisaturo M; Messina V; Sagnelli C; Macera M; Signoriello G; Sagnelli E
    J Clin Virol; 2009 Nov; 46(3):222-9. PubMed ID: 19758839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
    Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence and genotype distribution of hepatitis C virus in people living with HIV in Kathmandu, Nepal.
    Poudel KC; Poudel-Tandukar K
    Infect Dis (Lond); 2021 Jul; 53(7):521-530. PubMed ID: 33729860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, seroconversion and mother-to-child transmission of dual and triplex infections of HIV, hepatitis B and C viruses among pregnant women in Nigeria: study protocol.
    Eleje GU; Mbachu II; Ogwaluonye UC; Kalu SO; Onubogu CU; Nweje SI; Uzochukwu CE; Nwankwo CH; Fiebai PO; Loto OM; Akaba GO; Usman HA; Rabiu A; Egeonu RO; Igue OE; Adesoji BA; Jibuaku CH; Aja PO; Chidozie CP; Ibrahim HS; Aliyu FE; Numan AI; Okoro OD; Omoruyi SA; Oppah IC; Anyang UI; Ahmed A; Chukwurah SN; Umeononihu OS; Chukwuanukwu RC; Umeh EO; Emeka EA; Ogbuagu CN; Yakasai IA; Ezechi OC; Ikechebelu JI;
    Reprod Health; 2020 Sep; 17(1):144. PubMed ID: 32977846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.